title: Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients.
authors.affiliation: Division of Transplant Surgery, Department of Surgery, Medical Centre (Grosshadern), University of Munich, Munich, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Keunecke
authors.forename: U
authors.initials: U
authors.lastname: Rothenpieler
authors.forename: B
authors.initials: B
authors.lastname: Zanker
authors.forename: H
authors.initials: H
authors.lastname: Schneeberger
authors.forename: W D
authors.initials: WD
authors.lastname: Illner
authors.forename: J
authors.initials: J
authors.lastname: Theodorakis
authors.forename: M
authors.initials: M
authors.lastname: Stangl
authors.forename: W
authors.initials: W
authors.lastname: Land
mesh_terms: D000328:Adult; D001161:Arteriosclerosis / Q000517:prevention & control; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010865:Pilot Projects; D012449:Safety
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid